Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells

Area of Science:

• Pharmacology
• Cancer Biology
• Natural Products Chemistry

Background:

• Xanthones are natural compounds with potential anticancer properties.
• Structurally similar xanthones exhibit varying biological activities.
• Colon cancer remains a significant global health challenge.

Purpose of the Study:

• To investigate the antiproliferative effects of four prenylated xanthones (alpha-mangostin, beta-mangostin, gamma-mangostin, methoxy-beta-mangostin) on human colon cancer DLD-1 cells.
• To correlate the chemical structure of these xanthones with their antitumor efficacy.
• To elucidate the mechanisms underlying their antiproliferative effects, including apoptosis and cell-cycle arrest.

Main Methods:

• Cell culture of human colon cancer DLD-1 cells.
• Treatment with varying concentrations of four prenylated xanthones.
• Assessment of cell viability and proliferation.
• Apoptosis assays (Hoechst 33342 staining, DNA gel electrophoresis).
• Cell-cycle analysis and Western blotting for cell-cycle regulatory proteins (cyclins, cdc2, p27).

Main Results:

• Three of the four xanthones (alpha-mangostin, beta-mangostin, gamma-mangostin) significantly inhibited DLD-1 cell growth at 20 microM.
• Antitumor efficacy correlated positively with the number of hydroxyl groups on the xanthone structure.
• Alpha- and gamma-mangostin induced apoptosis, while all three effective xanthones caused cell-cycle arrest (G1 or S phase).

Conclusions:

• Prenylated xanthones, particularly those with more hydroxyl groups, demonstrate significant antiproliferative activity against colon cancer cells.
• Apoptosis induction and cell-cycle arrest are key mechanisms mediating the anticancer effects of these compounds.
• Xanthones show promise as agents for cancer prevention and as adjuncts in combination cancer therapy.